Validation of biological activity testing procedure of recombinant human interleukin-7

Area of Science:

• Biotechnology
• Immunology
• Cell Biology

Background:

• Recombinant human interleukin-7 (rhIL-7) is a key cytokine for T cell development and function.
• Accurate monitoring of rhIL-7 biological activity is crucial for its therapeutic applications and research.
• Existing methods may require refinement to meet stringent validation requirements.

Purpose of the Study:

• To develop and validate a robust method for monitoring the biological activity of rhIL-7.
• To establish a reliable assay for assessing rhIL-7's T lymphocyte proliferation-inducing capacity.
• To ensure the method adheres to national and international regulatory guidelines.

Main Methods:

• The study employed a cell-based assay measuring T lymphocyte proliferation induced by rhIL-7.
• Peripheral blood mononuclear cells (PBMCs) from donors or established cell lines were used as the biological test system.
• Standard validation parameters including specificity, accuracy, precision, and linearity were assessed.

Main Results:

• The developed method successfully demonstrated the ability of rhIL-7 to induce T lymphocyte proliferation.
• Validation testing confirmed satisfactory performance across all assessed parameters: specificity, accuracy, precision, and linearity.
• Both primary PBMCs and cell line-derived PBMCs proved suitable for biological activity control.

Conclusions:

• A validated method for controlling rhIL-7 biological activity has been established.
• The assay utilizing T lymphocyte proliferation is a reliable measure of rhIL-7 potency.
• This validated method provides a dependable tool for quality control of rhIL-7 products.